Log in to save to my catalogue

Betaine anhydrous in homocystinuria: results from the RoCH registry

Betaine anhydrous in homocystinuria: results from the RoCH registry

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_05d49c6bc6994b81a7acb386a29e24b7

Betaine anhydrous in homocystinuria: results from the RoCH registry

About this item

Full title

Betaine anhydrous in homocystinuria: results from the RoCH registry

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2019-03, Vol.14 (1), p.66-66, Article 66

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The Registry of Adult and Paediatric Patients Treated with Cystadane® - Homocystinuria (RoCH) is a non-interventional, observational, multi-centre, post-authorization safety study that aimed to identify safety of betaine anhydrous (Cystadane®) in the treatment of patients with inborn errors of homocysteine metabolism (homocystinuria) in order to mi...

Alternative Titles

Full title

Betaine anhydrous in homocystinuria: results from the RoCH registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_05d49c6bc6994b81a7acb386a29e24b7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_05d49c6bc6994b81a7acb386a29e24b7

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-019-1036-2

How to access this item